Infectious Disease
Research Areas
Products Related to Infectious Disease(1106)
- GC49187N-3-hydroxydecanoyl-DL-Homoserine lactoneCAS: 929222-14-0Purity: >98.00%
A bacterial quorum-sensing signaling molecule
- GC49188Sarafloxacin-d8 (hydrochloride)CAS: 2733145-07-6Purity: >99.00%
An internal standard for the quantification of sarafloxacin
- GC49208Maduramicin (ammonium salt)CAS: 84878-61-5Purity: >98.00%
Maduramicin (ammonium salt) (Maduramycin ammonium) is isolated from the actinomyceteActinomadura rubra.
- GC49268(+)-δ-CadineneCAS: 483-76-1Purity: >95.00%
A sesquiterpene with antimicrobial and anticancer activities
- GC492941-(4-Chlorobenzhydryl)piperazineCAS: 303-26-4Purity: >98.00%
An inactive metabolite of meclizine and chlorcyclizine
- GC493374-AcetamidobenzenesulfonamideCAS: 121-61-9Purity: >98.00%
A metabolite of asulam and sulfanilamide
- GC49357N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl esterCAS: 1354823-36-1Purity: >98.00%
A synthetic intermediate
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC49162 | N-Demethylvancomycin (hydrochloride) | 198774-23-1 | >95.00% | |
A glycopeptide antibiotic | ||||
| GC49165 | GS-441524 tris-isobutyryl ester | 2563617-99-0 | >98.00% | |
A prodrug form of GS-441524 | ||||
| GC49167 | (R)-(+)-Trityl glycidyl ether | 65291-30-7 | >98.00% | |
A synthetic precursor | ||||
| GC49170 | Biotin (S)-sulfoxide | 10406-89-0 | >95.00% | |
An inactive metabolite of biotin | ||||
| GC49177 | Loliolide | 5989-02-6 | >98.00% | |
Loliolide is a monoterpene lactone with diverse biological activities. | ||||
| GC49187 | N-3-hydroxydecanoyl-DL-Homoserine lactone | 929222-14-0 | >98.00% | |
A bacterial quorum-sensing signaling molecule | ||||
| GC49188 | Sarafloxacin-d8 (hydrochloride) | 2733145-07-6 | >99.00% | |
An internal standard for the quantification of sarafloxacin | ||||
| GC49200 | Biotin (R)-Sulfoxide | 3376-83-8 | >98.00% | |
A metabolite of biotin | ||||
| GC49208 | Maduramicin (ammonium salt) | 84878-61-5 | >98.00% | |
Maduramicin (ammonium salt) (Maduramycin ammonium) is isolated from the actinomyceteActinomadura rubra. | ||||
| GC49238 | 93-O17S | 2227008-67-3 | ≥95.00% | |
A cationic lipidoid | ||||
| GC49265 | PKI (14-22) amide (myristoylated) (trifluoroacetate salt) | - | >98.00% | |
A PKA inhibitor | ||||
| GC49267 | Hygromycin B-d4 | - | >99.00% | |
An internal standard for the quantification of hygromycin | ||||
| GC49268 | (+)-δ-Cadinene | 483-76-1 | >95.00% | |
A sesquiterpene with antimicrobial and anticancer activities | ||||
| GC49274 | Cefalonium | 5575-21-3 | >98.00% | |
A cephalosporin antibiotic | ||||
| GC49283 | 2-O-(α-D-Glucopyranosyl)glycerol | 22160-26-5 | >95.00% | |
A compatible solute | ||||
| GC49284 | GSK-A1 | 1416334-69-4 | >98.00% | |
GSK-A1 is a selective phosphatidylinositol 4-kinase IIIα (PI4KIIIα/PI4KA) inhibitor (pIC 50 =8.5-9.8). GSK-A1 inhibits PtdIns(4,5)P2 resynthesis (IC 50 =3nM). | ||||
| GC49287 | Faropenem (sodium salt hydrate) | 158365-51-6 | >98.00% | |
A penem antibiotic | ||||
| GC49294 | 1-(4-Chlorobenzhydryl)piperazine | 303-26-4 | >98.00% | |
An inactive metabolite of meclizine and chlorcyclizine | ||||
| GC49302 | Bactenecin (bovine) (trifluoroacetate salt) | - | >95.00% | |
A cationic peptide | ||||
| GC49306 | Isopimaric Acid | 5835-26-7 | >98.00% | |
A diterpenoid resin acid | ||||
| GC49337 | 4-Acetamidobenzenesulfonamide | 121-61-9 | >98.00% | |
A metabolite of asulam and sulfanilamide | ||||
| GC49357 | N-[(S)-(4-Nitrophenoxy)phenoxyphosphinyl]-L-alanine 2-ethylbutyl ester | 1354823-36-1 | >98.00% | |
A synthetic intermediate | ||||
| GC49360 | Antimycin A Complex | 1397-94-0 | >95.00% | |
A bacterial metabolite complex | ||||
| GC49365 | 25-Desacetyl Rifampicin | 16783-99-6 | >95.00% | |
A major active metabolite of rifampicin | ||||